Administration of Paroxetine Attenuates cognitive functon by using fMRI.
Phase 4
- Conditions
- depression
- Registration Number
- JPRN-UMIN000002977
- Lead Sponsor
- Tamagawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
patients with psychiatric disorder patients with hepatic, kidney, cardiac disorders patients taking other drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison between placebo, non drug, SSRI conditions.
- Secondary Outcome Measures
Name Time Method